Advanced company searchLink opens in new window

CATALENT PHARMA SOLUTIONS LIMITED

Company number 03761135

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
03 Apr 2020 CS01 Confirmation statement made on 20 March 2020 with no updates
23 Sep 2019 PSC02 Notification of Catalent, Inc. as a person with significant control on 6 April 2016
19 Sep 2019 PSC09 Withdrawal of a person with significant control statement on 19 September 2019
11 Sep 2019 TM02 Termination of appointment of Kirk Walsh as a secretary on 30 August 2019
03 Apr 2019 CS01 Confirmation statement made on 20 March 2019 with no updates
11 Mar 2019 AA Full accounts made up to 30 June 2018
12 Jun 2018 SH20 Statement by Directors
12 Jun 2018 SH19 Statement of capital on 12 June 2018
  • GBP 3
12 Jun 2018 CAP-SS Solvency Statement dated 31/05/18
12 Jun 2018 RESOLUTIONS Resolutions
  • RES13 ‐ Share premium a/c be cancelled 31/05/2018
25 Apr 2018 AP03 Appointment of Mr Alex Reed as a secretary on 29 March 2018
25 Apr 2018 AP01 Appointment of Mr Jonathan Arnold as a director on 29 March 2018
24 Apr 2018 TM01 Termination of appointment of Barry Littlejohns as a director on 29 March 2018
20 Mar 2018 CS01 Confirmation statement made on 20 March 2018 with no updates
11 Oct 2017 AA Full accounts made up to 30 June 2017
06 Apr 2017 AA Full accounts made up to 30 June 2016
22 Mar 2017 CS01 Confirmation statement made on 20 March 2017 with updates
13 Dec 2016 AP01 Appointment of Mr Aristippos Gennadios as a director on 8 December 2016
18 Jul 2016 SH01 Statement of capital following an allotment of shares on 29 June 2016
  • GBP 3
14 Jul 2016 CC04 Statement of company's objects
14 Jul 2016 MA Memorandum and Articles of Association
14 Jul 2016 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of alteration of Articles of Association
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
21 Mar 2016 AR01 Annual return made up to 20 March 2016 with full list of shareholders
Statement of capital on 2016-03-21
  • GBP 2
23 Dec 2015 AA Full accounts made up to 30 June 2015
23 Mar 2015 AR01 Annual return made up to 20 March 2015 with full list of shareholders
Statement of capital on 2015-03-23
  • GBP 2